S Petruzzelli, LM Tavanti, A Celi and C Giuntini
U.O. Fisiopatologia Respiratoria, Clinica Medica 2a, Universita di Pisa, Italy.

Alkylating agents may cause DNA damage in different human cells and tissues, including lungs. For instance, tobacco-specific N-nitrosamines are known to produce methyl-DNA adducts, such as N7- methyldeoxyguanosine, and to induce lung tumors. We applied a combined high-performance liquid chromatography (HPLC)/32P-postlabeling technique for measurement of N7-methyldeoxyguanosine in human pulmonary alveolar cells (HPAC). Thirty patients (13 males, 17 females; mean age 51 +/- 17 yr) undergoing bronchoalveolar lavage for diagnosis of nonmalignant lung diseases were studied. DNA was extracted from HPAC, digested to 2'-deoxyribonucleotide 3'-monophosphates and HPLC separated to obtain deoxyguanosine (dGp) and N7-methyldeoxyguanosine (N7-MedGp) monophosphates. Fractions corresponding to normal (1:10,000) and N7- methylated dGp were subsequently 32P-postlabeled by T4 polynucleotide kinase with high specific activity 32P-ATP, resolved by two-dimensional thin-layer chromatography (TLC) and autoradiographed after 3 to 18 h exposure. Spots corresponding to dGp and N7-MedGp were scraped off the plates and quantitated by liquid scintillation counting to calculate direct molar ratios. Recovered HPAC (14.4 +/- 10.0 x 10(6)) were predominantly macrophages (73.8 +/- 16.4%) and lymphocytes (9.8 +/- 11.6%). N7-MedGp was detected in 11 patients, the level ranging from 0.10 to 48.03 fmol/micrograms DNA which corresponded to 0.31-79.00 x 10(-6) N7-MedGp/dGp ratios. Detection of N7-MedGp in HPAC was associated with the smoking habit of patients: N7-MedGp was present in 7 of 10 smokers, 2 of 10 ex-smokers, and 2 of 10 nonsmokers (P < 0.05). These results show that HPAC may be used for molecular dosimetry of DNA damage by alkylating agents, including tobacco-specific N-nitrosamines, in cigarette smokers and thus used for cancer risk assessment.

This article has been cited by other articles:

				S. S. Hecht DNA Adducts of Tobacco Smoke Carcinogens Am. Assoc. Cancer Res. Educ. Book, April 1, 2006; 2006(1): 217 - 222. [Full Text] [PDF]

				F. J. Van Schooten, A. W. Boots, A. M. Knaapen, R. W. L. Godschalk, L. M. Maas, P. J. A. Borm, M. Drent, and J. A. Jacobs Myeloperoxidase (MPO) -463G->A Reduces MPO Activity and DNA Adduct Levels in Bronchoalveolar Lavages of Smokers Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 828 - 833. [Abstract] [Full Text] [PDF]

				P. Georgiadis, E. Samoli, S. Kaila, K. Katsouyanni, and S. A. Kyrtopoulos Ubiquitous Presence of O6-Methylguanine in Human Peripheral and Cord Blood DNA Cancer Epidemiol. Biomarkers Prev., March 1, 2000; 9(3): 299 - 305. [Abstract] [Full Text]

				S. S. Hecht Tobacco Smoke Carcinogens and Lung Cancer J Natl Cancer Inst, July 21, 1999; 91(14): 1194 - 1210. [Abstract] [Full Text] [PDF]

				F. Fernandez-Madrid, P. J. VandeVord, X. Yang, R. L. Karvonen, P. M. Simpson, M. J. Kraut, J. L. Granda, and J. E. Tomkiel Antinuclear Antibodies as Potential Markers of Lung Cancer Clin. Cancer Res., June 1, 1999; 5(6): 1393 - 1400. [Abstract] [Full Text] [PDF]

				S Petruzzelli, R Puntoni, P Mimotti, N Pulera, F Baliva, E Fornai, and C Giuntini Plasma 3-nitrotyrosine in cigarette smokers Am. J. Respir. Crit. Care Med., December 1, 1997; 156(6): 1902 - 1907. [Abstract] [Full Text]

				J. E. REPINE, A. BAST, I. LANKHORST, and The Oxidative Stress Study Gro Oxidative Stress in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 341 - 357. [Full Text]